What is the current Price Target for the Acumen Pharmaceuticals Inc stock?

The average Acumen Pharmaceuticals Inc target price is $8.16. This is 265.10% higher than the current stock price. The highest price target is 369.80%, the lowest is 80.76%. 7 Analysts have issued a price target Acumen Pharmaceuticals Inc 2027 .

How high will the Acumen Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Acumen Pharmaceuticals Inc stock will rise. The performance of stocks, including the Acumen Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Acumen Pharmaceuticals Inc stock today?

The performance of Acumen Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Acumen Pharmaceuticals Inc stock fall?

The decline in Acumen Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Acumen Pharmaceuticals Inc Forecast, price target & analysts

$2.24

3.04%

Nasdaq, Sep 24, 04:00 pm EDT. Closed.

ISIN

US00509G2093

Symbol

ABOS

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Analysts Charts Ownership News Strategies

Acumen Pharmaceuticals Inc Target price 2026 - Analyst rating & recommendation

Acumen Pharmaceuticals Inc Classifications & Recommendation

Buy

92%

Hold

Acumen Pharmaceuticals Inc Price Target

Target Price	$8.16
Price	$2.24
Potential	265.10% register free of charge
Number of Estimates	7

	7 Analysts have issued a price target Acumen Pharmaceuticals Inc 2027 . The average Acumen Pharmaceuticals Inc target price is $8.16. This is 265.10% register free of charge higher than the current stock price. The highest price target is $10.50 369.80% register free of charge , the lowest is $4.04 80.76% register free of charge .
	A rating was issued by 12 analysts: 11 Analysts recommend Acumen Pharmaceuticals Inc to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Acumen Pharmaceuticals Inc stock has an average upside potential 2027 of 265.10% register free of charge . Most analysts recommend the Acumen Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually

	Dec '25	2026 Estimates
P/E		negative

8 Analysts have issued a Acumen Pharmaceuticals Inc forecast for earnings per share. The average Acumen Pharmaceuticals Inc EPS is

unlock

. This is

unlock

than earnings per share in the financial year 2025. The highest EPS forecast is

unlock

, the lowest is

unlock

This results in the following potential growth metrics and future valuations:

2027	$-1.55 0.64% unlock
2028	$-1.28 17.42% unlock

Current	-1.54	177.68%
2026	-1.48 6.90% unlock
2027	-1.49 0.68% unlock
2028	-1.80 20.81% unlock

Acumen Pharmaceuticals Inc...

Current Acumen Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
BTIG	Locked ➜ Locked	Locked	Sep 16 2026
Citigroup	Locked ➜ Locked	Locked	Sep 15 2026
BTIG	Locked ➜ Locked	Locked	Mar 26 2026
BTIG	Locked ➜ Locked	Locked	Mar 16 2026
BTIG	Locked ➜ Locked	Locked	Jan 27 2026
B of A Securities	Locked ➜ Locked	Locked	Nov 18 2025
B of A Securities	Locked ➜ Locked	Locked	Aug 25 2025

Analyst Rating	Date
Locked BTIG: Locked ➜ Locked	Sep 16 2026
Locked Citigroup: Locked ➜ Locked	Sep 15 2026
Locked BTIG: Locked ➜ Locked	Mar 26 2026
Locked BTIG: Locked ➜ Locked	Mar 16 2026
Locked BTIG: Locked ➜ Locked	Jan 27 2026
Locked B of A Securities: Locked ➜ Locked	Nov 18 2025
Locked B of A Securities: Locked ➜ Locked	Aug 25 2025

Discover more stocks with a high price target

NIO ADR 101.75%

Alibaba Group Holding Ltd 67.67%

Tencent Holdings Ltd. 55.89%

Uber Technologies 48.83%

Siemens Energy 47.15%

Adidas 46.64%

BYD 44.49%

Deutsche Telekom 38.45%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now